Breast Cancer: Clinical Trials & Research

You may be offered the opportunity to take part in a clinical trial at some point during your treatment for breast cancer. Clinical trials are research studies that evaluate the safety and effectiveness of new treatment approaches for diseases. In some cases, a study may give you access to new therapies hat are not yet readily available.

Sometimes we use clinical trials to compare diagnostic tests, prevention strategies, or other aspects of care.

Showing 51 - 68 of 68 trials
Title Investigatorsort icon
A Phase II Study of BMN 673 (Talazoparib) in Patients with Locally Advanced or Metastatic Breast Cancer Containing a BRCA Mutation
[Protocol 14-253]
Robson, Mark, MD
Understanding Decision-Making Processes for Undergoing Genetic Testing Among Women with Newly Diagnosed Breast Cancer
[Protocol 11-086]
Robson, Mark, MD
A Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116]
Roth, Andrew, MD
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169]
Rusch, Valerie, MD
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew, MD
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068]
Stadler, Zsofia, MD
A Study Comparing Whole Breast Ultrasound with Contrast-Enhanced Digital Mammography for Breast Cancer Screening
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-240]
Sung, Janice, MD
A Study Comparing Whole Breast Screening Ultrasound with 3D Mammography (Digital Breast Tomosynthesis) in Women Scheduled for Digital Mammography and Ultrasound
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-119]
Sung, Janice, MD
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
[Protocol 12-089]
Tew, William, MD
A Phase II Study of Exemestane with and without Enzalutamide in Women with Advanced Hormone Receptor-Positive Breast Cancer
[Protocol 13-257]
Traina, Tiffany, MD
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190]
Traina, Tiffany, MD
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155]
Traina, Tiffany, MD
A Study of Imaging to Detect HER2 Positive Cancer Cells in Women with Breast Cancer, to Guide the Use of HER2 Targeted Therapies
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-156]
Ulaner, Gary, MD, PhD
FACBC Positron Emission Tomography and Positron Emission Mammography to Evaluate Response to Breast Cancer Chemotherapy
[Protocol 11-177]
Ulaner, Gary, MD, PhD
A Study Assessing Fluorestradiol PET/CT for Imaging Estrogen Receptor Status
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-071]
Ulaner, Gary, MD, PhD
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023]
Van Zee, Kimberly, MD
A Phase I Study of Debio1347 in Patients with Advanced Cancers Containing FGFR Alterations
[Protocol 13-131]
Voss, Martin, MD
A Phase II Study to See if Carvedilol Can Help Prevent Heart Function Problems in Women Receiving Anthracyclines or Anti-HER2 Therapies for Breast Cancer
[Protocol 14-099]
Yu, Anthony, MD